FGF7 and breast carcinoma: The breast cancer cell lines were treated with FGF7 or FGF10 for 1 or 8 min., and such early signalling was analysed using phosphoproteomics, hereafter referred to as trafficking phosphoproteomics approach 1 (TPA1) (Fig 1A).